- Home
- MBOT vs INO Comparison
MBOT vs INO Comparison
Compare MBOT & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBOT | INO |
|---|---|---|
| Founded | 2010 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.7M | 116.1M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | MBOT | INO |
|---|---|---|
| Price | $1.98 | $1.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $8.75 | ★ $9.00 |
| AVG Volume (30 Days) | 1.1M | ★ 1.8M |
| Earning Date | 11-12-2025 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $182,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3,119.61 | $23,060.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.25 | $1.30 |
| 52 Week High | $4.67 | $2.98 |
Technical Indicators
Market Signals| Indicator | MBOT | INO |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 36.24 |
| Support Level | $1.96 | $1.47 |
| Resistance Level | $2.21 | $1.57 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 5.66 | 16.00 |
Price Performance
Historical ComparisonAbout MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.